Hno International, Inc. (HNOI) intrinsic value & 10-year financials
Hno International, Inc. (HNOI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 5 fiscal years revenue grew 23.9% a year to $65.6K, with an average return on invested capital of 333.9%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.04
- Market cap
- $6.1M
- Revenue (FY2025)
- $65.6K
- Revenue growth (5-yr CAGR)
- 23.9%
- ROIC (10-yr avg)
- 333.9%
- Free cash flow (FY2025)
- -$1.2M
HNOI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $65.6K | -$6.6M | -$0.04 | -$1.2M | -10090.6% | 443.1% |
| FY2024 | $4.2K | -$2.2M | -$0.01 | -$2.2M | -52587.2% | 265.7% |
| FY2023 | $13.0K | -$1.4M | $0.00 | -$2.2M | -11087.2% | 440.3% |
| FY2022 | $34.5K | -$1.1M | -$0.01 | -$1.1M | -3109.8% | 186.4% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
HNO International, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
HNO International, Inc. has historically struggled to out-earn its cost of capital, averaging just 3.3% ROIC.
HNO International, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, HNO International, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-1.33 per share.